4//SEC Filing
Kantoff Philip W. 4
Accession 0001842952-23-000062
CIK 0001842952other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:53 PM ET
Size
5.5 KB
Accession
0001842952-23-000062
Insider Transaction Report
Form 4
Kantoff Philip W.
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-31+25,000→ 25,000 totalExercise: $0.87Exp: 2033-05-30→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001866025
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:53 PM ET
- Size
- 5.5 KB